Home/Theradiag/Sébastien Lapeyre
SL

Sébastien Lapeyre

Chief Financial Officer

Theradiag

Theradiag Pipeline

DrugIndicationPhase
Lisa-Tracker ExtensionsAutoimmune DiseasesDevelopment/CE Marking
Prestizia Oncology PanelsSolid TumorsCommercial/Market Expansion
Digital PCR Assay DevelopmentOncology & Infectious DiseasesR&D/Validation
Companion Diagnostic Co-DevelopmentOncology TargetsPartnership/Regulatory